Research ArticleOriginal Article
Open Access

Practice of thyroid nodule management in the Gulf Cooperation Council countries

Anwar A. Jammah
Saudi Medical Journal January 2021, 42 (1) 66-74; DOI: https://doi.org/10.15537/smj.2021.1.25591

References

  1. ↵
    1. Zhang Y,
    2. Wu Q,
    3. Chen Y,
    4. Wang Y
    (2020) A clinical assessment of an ultrasound computer-aided diagnosis system in differentiating thyroid nodules with radiologists of different diagnostic experience. Front Oncol 10:557169.
    OpenUrl
  2. ↵
    1. Ye H,
    2. Hang J,
    3. Chen X,
    4. Di Xu,
    5. Chen J,
    6. Ye X,
    7. Zhang D
    (2020) An intelligent platform for ultrasound diagnosis of thyroid nodules. Sci Rep 10:13223.
    OpenUrl
  3. ↵
    1. Lim H,
    2. Devesa SS,
    3. Sosa JA,
    4. Check DA,
    5. Kitahara CM
    (2017) Trends in thyroid cancer incidence and mortality in the United States 1974-2013. JAMA 317:1338–1348.
    OpenUrlCrossRefPubMed
    1. Remonti LR,
    2. Kramer CK,
    3. Leitao CB,
    4. Pinto LC,
    5. Gross JL
    (2015) Thyroid ultrasound features and risk of carcinoma:A systematic review and meta-analysis of observational studies. Thyroid 25:538–550.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Nikiforov YE,
    2. Carty SE,
    3. Chiosea SI,
    4. Coyne C,
    5. Duvvuri U,
    6. Ferris L,
    7. et al.
    (2015) Impact of the multi-gene throes next-generation sequencing assay on cancer diagnosis in thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance cytology. Thyroid 25:1217–1223.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Or K,
    2. Benbassat C,
    3. Koren S,
    4. Shteinshneider M,
    5. Koren R,
    6. Cantrell D,
    7. et al.
    (2018) Adherence to ATA 2015 guidelines in the management of unifocal non-invasive papillary thyroid cancer:a clinical survey among endocrinologists and surgeons. Eur Arch Otorhinolaryngol 275:2851–2859.
    OpenUrl
  7. ↵
    1. Alexander EK,
    2. Schorr M,
    3. Klopper J,
    4. Kim C,
    5. Sipos J,
    6. Nabhan F,
    7. et al.
    (2014) Multicenter clinical experience with the Affirma gene expression classifier. J Clin Endocrinol Metab 99:119–125.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Ahn HS,
    2. Kim HJ,
    3. Welch HG
    (2014) Korea's thyroid-cancer “epidemic”- screening and overdiagnosis. N Engl J Med 371:1765–1767.
    OpenUrlCrossRefPubMedWeb of Science
    1. Haugen BR,
    2. Alexander EK,
    3. Bible KC,
    4. Doherty GM,
    5. Mandel SJ,
    6. Nikiforov YE,
    7. et al.
    (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:The American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–13.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Bennedbaek FN,
    2. Hegedus L
    (2000) Management of the solitary thyroid nodule:Results of a North American survey. J Clin Endocrinol Metab 85:2493–2498.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Alshehri BM
    (2020) Trends in the incidence of oral cancer in Saudi Arabia from 1994 to 2015. World J Surg Oncol 18:1–6.
    OpenUrl
  12. ↵
    1. Choi BC,
    2. Pak AW
    (2005) A catalog of biases in questionnaires. Prev Chronic Dis 2:A13.
    OpenUrlPubMed
    1. Soto-Rey I,
    2. Dugas M,
    3. Fritz F
    (2015) Clinical trial feasibility study questionnaire analysis. Stud Health Technol Inform 216:1029.
    OpenUrl
  14. ↵
    1. Joseph-Auguste J,
    2. Lin L,
    3. Demar M,
    4. Duffas O,
    5. Molinie V,
    6. Sulpicy C,
    7. et al.
    (2020) Epidemiologic, clinical, ultrasonographic, and cytological features of thyroid nodules in predicting malignancy risk:A retrospective study of 442 French Afro-Caribbean patients. Int J Endocrinol 2020:4039290.
    OpenUrl
  15. ↵
    1. Koshkina A,
    2. Fazelzad R,
    3. Sugitani I,
    4. Miyauchi A,
    5. Thabane L,
    6. Goldstein DP,
    7. et al.
    (2020) Association of patient age with progression of low-risk papillary thyroid carcinoma under active surveillance:A systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg 146:552–560.
    OpenUrl
  16. ↵
    1. Haugen BR
    (2017) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer:What is new and what has changed? Cancer 123:372–381.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Labourier E
    (2016) Utility and cost-effectiveness of molecular testing in thyroid nodules with indeterminate cytology. Clin Endocrinology 85:624–631.
    OpenUrl
    1. Valderrabano P,
    2. McIver B
    (2017) Evaluation and management of indeterminate thyroid nodules:The revolution of risk stratification beyond cytological diagnosis. Cancer Control 14:1073274817729231.
    OpenUrl
  19. ↵
    1. Roth MY,
    2. Witt RL,
    3. Steward DL
    (2018) Molecular testing for thyroid nodules:review and current state. Cancer 124:888–898.
    OpenUrl
  20. ↵
    1. Jiang L,
    2. Lee CY,
    3. Sloan DA,
    4. Randle RW
    (2019) Variation in the quality of thyroid nodule evaluations before surgical referral. J Surg Res 244:9–14.
    OpenUrl
  21. ↵
    1. Russ G,
    2. Bonnema SJ,
    3. Erdogan MF,
    4. Durante C,
    5. Ngu R,
    6. Leenhardt L
    (2017) European Thyroid Association Guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults:The EU-TIRADS. Eur Thyroid J 6:225–237.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Tessler FN,
    2. Middleton WD,
    3. Grant EG,
    4. Hoang JK,
    5. Berland LL,
    6. Teefey SA,
    7. et al.
    (2017) ACR thyroid imaging, reporting and data system (TI-RADS):White paper of the ACR TI-RADS committee. J Am Coll Radiol 14:587–595.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Bahaj AS,
    2. Alkaff HH,
    3. Melebari BN,
    4. Sayed SI,
    5. Mujitaba SS,
    6. Abdelmonim SK,
    7. et al.
    (2020) Role of fine-needle aspiration cytology in evaluating thyroid nodules. A retrospective study from a tertiary care center of Western region, Saudi Arabia. Saudi Med J 41:1098–1103.
    OpenUrlAbstract/FREE Full Text
    1. Haugen BR,
    2. Sawka AM,
    3. Alexander EK,
    4. Bible KC,
    5. Caturegli P,
    6. Doherty GM,
    7. et al.
    (2017) American thyroid association guidelines on the management of thyroid nodules and differentiated thyroid cancer task force review and recommendation on the proposed renaming of encapsulated follicular variant papillary thyroid carcinoma without invasion to noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid 27:481–483.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Verburg FA,
    2. Aktolun C,
    3. Chiti A,
    4. Frangos S,
    5. Giovanella L,
    6. Hoffmann M,
    7. et al.
    (2016) Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 43:1001–1005.
    OpenUrl
    1. Yi KH
    (2016) The revised 2016 Korean Thyroid Association guidelines for thyroid nodules and cancers:differences from the 2015 American Thyroid Association guidelines. Endocrinol Metab (Seoul) 31:373–378.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords